Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.9% in the third quarter, HoldingsChannel reports. The institutional investor owned 480,202 shares of the medical equipment provider’s stock after selling 52,717 shares during the period. New York State Common Retirement Fund’s holdings in Intuitive Surgical were worth $235,909,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of ISRG. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the second quarter valued at $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC grew its position in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. Finally, Delos Wealth Advisors LLC increased its stake in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Truist Financial lifted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Raymond James boosted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $3.06 during trading on Friday, reaching $506.90. The stock had a trading volume of 70,185 shares, compared to its average volume of 1,456,329. The stock has a market capitalization of $180.55 billion, a PE ratio of 81.00, a P/E/G ratio of 5.05 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $269.49 and a 52 week high of $523.34. The business’s 50-day moving average price is $490.01 and its 200 day moving average price is $445.70.

Insider Buying and Selling at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.